Related Experiment Videos
Temporal bone and lateral skull base malignancy: experience and results with 81 patients
S Manolidis1, D Pappas, P Von Doersten
1The Bobby R. Alford Department of Otolaryngology, Baylor College of Medicine, Houston, Texas 77030, USA.
The American Journal of Otology
|November 25, 1998
Summary
Malignant lateral skull base tumors are rare but challenging. Prognosis depends on histology and extent, with pain and facial nerve issues indicating a worse outcome.
Area of Science:
- Neurosurgery
- Oncology
- Otolaryngology
Background:
- Malignant lateral skull base disease is a rare clinical challenge.
- Understanding predictive factors and treatment outcomes is crucial for improving patient care.
- Developing a standardized staging method is needed for this rare entity.
Purpose of the Study:
- To identify predictive factors for treatment outcomes in malignant lateral skull base disease.
- To analyze treatment success rates and survival data.
- To propose a novel staging system for malignant lateral skull base lesions.
Main Methods:
- Retrospective review of 81 patients with malignant lateral skull base disease treated at a tertiary referral center.
- Classification of malignancies into epithelial, salivary gland, and mesenchymal origins.
- Analysis of prognostic indicators including cranial nerve deficits, complications, and survival.
Main Results:
- A 58% treatment success rate was observed.
- Epithelial and salivary gland malignancies demonstrated a poorer prognosis compared to mesenchymal tumors.
- Presence of pain and facial nerve deficits at presentation were associated with worse outcomes.
Conclusions:
- Malignant lateral skull base disease presents significant challenges for surgeons, with frequent cranial nerve deficits and complications.
- Treatment success is significantly influenced by tumor histology and the extent of disease.
- Further research and standardized staging are essential for optimizing management strategies.